Testing effectiveness (Phase 2)Study completedNCT01949467
What this trial is testing
Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis.
Who this might be right for
Hemochromatosis, Type 4Ferroportin DiseaseDysmetabolic Hepatosiderosis+1 more
Rennes University Hospital 62